JPRN-jRCT1011210031招募中未知
A multicenter study to investigate Oral JAK inhibitor Pharmacogenomics and Exposure-Response relationship in Japanese adult patients with moderately to severely Active ulcerative colitis during the COVID-19 pandemic - OPERA study
Fukudo Masahide0 个研究点目标入组 50 人开始时间: 2021年8月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Subjects must meet all of the following inclusion criteria to be eligible for enrollment into the study:
- •1. Subject must be at least 20 years of age.
- •2. Subjects with a documented diagnosis of moderately to severely active ulcerative colitis.
- •3. Subjects who can provide informed consent.
排除标准
- •Subjects presenting with any of the following will be excluded from the study:
- •1. Subjects who cannot provide informed consent.
- •2. Subjects who are participating in or interested in participating in other clinical
- •trials during the study period.
- •3. Subjects who are judged as not suitable for participating in this study by treating physician.
研究者
相似试验
进行中（未招募）
不适用
A Randomized Study of the JAK Inhibitor INCB018424 Tablets Compared to Best Available Therapy in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) - COMFORT IIMedDRA version: 12.0Level: LLTClassification code 10028537Term: MyelofibrosisMyelofibrosisEUCTR2009-009858-24-ITIncyte Corporation150
尚未招募
Unknown
A comparative study between efficacy of topical JAK inhibitor alone versus JAK inhibitor with phototherapy in vitiligo patientsCTRI/2024/07/070001Dr Sneha Ulhaskumar Arakeri
进行中（未招募）
3 期
To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic ArthritisPsoriatic ArthritisNCT04957550Jiangsu HengRui Medicine Co., Ltd.418
进行中（未招募）
1 期
Inhibition of JAK Enzymes in early stage Joint inflammatioPreclinical Phase of rheumatoid arthritisMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2021-006562-20-DEniversitätsklinikum Erlangen20
尚未招募
不适用
Influence of JAK inhibitors on the disease-associated network of intestinal immune cells in ulcerative colitisUlcerative ColitisNL-OMON51787eids Universitair Medisch Centrum70